The Chequers summit on 6 July and the subsequent resignation of ministers illustrates how controversial it is to decide whether the UK should share a “common rule book” with the EU after Brexit, or set up its own independent regulators. In this blog, Derek Hill looks at the regulation of medicines and medical devices as examples of the thin margin of action that the UK … Continue reading Can the UK be an independent leading regulator in the development of new medicines and medical devices?
John Martin draws from his personal experience as a member of the European Society of Cardiology to explain the benefits of European cooperation in medical research and beyond. He stresses the need for the UK to join the moral leadership championed by the EU in the world. I am as British as any Brexiteer. I served as Regimental Medical Officer in the Ghurkha Field Force … Continue reading A Cardiologist Views Brexit
An infographic compiled by international healthcare network MEDIGO explores some of the facts and figures behind claims from both sides of the EU referendum campaign about the NHS. In this post, marketing manager Andrew Cherrie explains the motivation behind putting this together. The National Health Service has always been used for point scoring across all sections of the political spectrum, with the level of polemic … Continue reading Brexit and the NHS: The figures behind the claims
John Martin, Professor of Cardiovascular Medicine at UCL, argues that scientific advance relies on creativity, cooperation, and financing. To leave the EU would diminish all three, dimming the light of British science in the world and threatening the UK’s future economy. This piece is part of the UCL European Institute’s commissioning partnership with openDemocracy. For more on this topic, join the UCL European Institute for its high-level panel discussion EU … Continue reading EU referendum: the view of a UCL clinician-scientist